Diagnostic Criteria and Prognosis of Pancreatic Lymphoma

This entry looks at pancreatic lymphoma, or primary pancreatic lymphoma (PPL), one of the subtypes of lymphoma. 'Lymphoma' is an umbrella term that loosely refers to several dozen independent categorical types and subtypes of cancers of the lymphatic system.

What is Pancreatic Lymphoma?

Primary pancreatic lymphoma is a cancer of the lymphocytes that originates as a pancreatic mass, and is not the result of an invasion from nearby lymph nodes. It is important that a pancreatic mass be quickly identified as either a lymphoma or an adenocarcinoma, since each is approached differently from a treatment perspective and the latter is far more serious.

Primary pancreatic lymphoma appears to be much more common in men than in women, but it is by any standard a very rare disease. It represents about 1 percent of all pancreatic masses, and about 1 percent of extra-nodal non-Hodgkin's lymphomas, making for a rather small number indeed. However, secondary pancreatic lymphoma, in which lymphoma spreads to the pancreas, is a fairly common organ for extra-nodal involvement as a secondary site.

Diagnostic Criteria for Pancreatic Lymphoma

There are three criteria in order to diagnose PPL. They are:

  1. No lymph node enlargement of superficial or mediastinal lymph nodes;
  2. A normal leukocyte count in the peripheral blood;
  3. No involvement of the liver or spleen.

Symptoms of Pancreatic Lymphoma

Signs and symptoms of PPL are generally non-specific, meaning they could indicate many things in addition to PPL. A person could experience abdominal pain of variable severity and small bowel obstruction, along with the constellation of B symptoms, including loss of appetite, unexplained weight loss, fatigue, and night sweats.

Furthermore, patients with pancreatic lymphoma tend to have normal white blood cell counts. A trademark of the disease from the laboratory perspective is elevated LDH.

Treatment and Prognosis for Pancreatic Lymphoma

Treatment for PPL can include surgery (surgical resection), combination chemotherapy, or sometimes radiation along with chemotherapy. Studies suggest that when treated with chemotherapy, prognosis for PPL is very good.

Sources

Photo: Pixabay

lymphoma roundup

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...